Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norepinephrine vs FFP for Renal Protection in HIPEC
NCT04683614Completed
- Sponsor
- National Cancer Institute
- Start
- Oct 2020
- Primary completion
- May 2022
- Modality
- Recombinant Proteins and Enzymes, Tissue Cells, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of norepinephrine and fresh-frozen plasma in acute kidney injury (AKI), sponsored by National Cancer Institute. Primary endpoint: Renal insult at 24 hours. Started Oct 2020; status: completed.
02
Drugs
norepinephrinefresh-frozen plasma
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT04683614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04683614.